Suppr超能文献

非侵入性免疫组织化学诊断和导致常染色体显性遗传性肾小管间质性肾病的新型突变。

Noninvasive Immunohistochemical Diagnosis and Novel Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.

机构信息

Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine.

Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

出版信息

J Am Soc Nephrol. 2018 Sep;29(9):2418-2431. doi: 10.1681/ASN.2018020180. Epub 2018 Jul 2.

Abstract

BACKGROUND

Autosomal dominant tubulointerstitial kidney disease caused by mucin-1 gene () mutations (ADTKD-) is characterized by progressive kidney failure. Genetic evaluation for ADTKD- specifically tests for a cytosine duplication that creates a unique frameshift protein (MUC1fs). Our goal was to develop immunohistochemical methods to detect the MUC1fs created by the cytosine duplication and, possibly, by other similar frameshift mutations and to identify novel mutations in individuals with positive immunohistochemical staining for the MUC1fs protein.

METHODS

We performed MUC1fs immunostaining on urinary cell smears and various tissues from ADTKD-positive and -negative controls as well as in individuals from 37 ADTKD families that were negative for mutations in known ADTKD genes. We used novel analytic methods to identify frameshift mutations.

RESULTS

After technique refinement, the sensitivity and specificity for MUC1fs immunostaining of urinary cell smears were 94.2% and 88.6%, respectively. Further genetic testing on 17 families with positive MUC1fs immunostaining revealed six families with five novel frameshift mutations that all predict production of the identical MUC1fs protein.

CONCLUSIONS

We developed a noninvasive immunohistochemical method to detect MUC1fs that, after further validation, may be useful in the future for diagnostic testing. Production of the MUC1fs protein may be central to the pathogenesis of ADTKD-.

摘要

背景

由黏蛋白 1 基因 () 突变引起的常染色体显性遗传性肾小管间质性肾病 (ADTKD-) 的特征是进行性肾衰竭。ADTKD-的基因评估专门测试是否存在导致独特移码蛋白 (MUC1fs) 的胞嘧啶重复。我们的目标是开发免疫组织化学方法来检测由胞嘧啶重复产生的 MUC1fs,以及可能由其他类似移码突变产生的 MUC1fs,并鉴定出免疫组织化学染色呈 MUC1fs 蛋白阳性的个体中的新突变。

方法

我们对 ADTKD 阳性和阴性对照的尿液细胞涂片和各种组织进行了 MUC1fs 免疫染色,同时还对已知 ADTKD 基因无突变的 37 个 ADTKD 家系中的个体进行了 MUC1fs 免疫染色。我们使用新的分析方法来鉴定移码突变。

结果

经过技术改进,尿液细胞涂片 MUC1fs 免疫染色的敏感性和特异性分别为 94.2%和 88.6%。对 17 个 MUC1fs 免疫染色阳性的家系进行进一步的基因检测,发现有 5 个家系存在 5 个新的移码突变,均预测产生相同的 MUC1fs 蛋白。

结论

我们开发了一种非侵入性的免疫组织化学方法来检测 MUC1fs,该方法在进一步验证后,将来可能对诊断测试有用。MUC1fs 蛋白的产生可能是 ADTKD-发病机制的核心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/184d/6115665/a8a71beb8d86/ASN.2018020180absf1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验